Screening Cell-Penetrating Peptides That Improve Drug Absorption Without Harming Gut Bacteria

Out of 9 cell-penetrating peptides tested, 4 significantly improved intestinal paracellular permeability without compromising cell health. Among these, the synthetic CPPs Shuffle and Penetramax were the top performers, increasing permeability at 50 µM concentration while having only small to moderate antimicrobial effects on tested gut commensal strains. The other 4 CPPs that improved permeability had more substantial negative effects on nearly all tested gut bacteria.

Researchers tested 9 CPPs using a differentiated Caco-2 epithelial monolayer model (a standard lab model of the intestinal barrier). Cytotoxicity was measured with Cytotox Red dye staining, cell viability with AlamarBlue staining, and paracellular permeability by transport assays. The 4 best-performing CPPs were then tested against 10 representative gut bacteria strains using microbroth dilution assays.

Many promising drugs fail because they can't be absorbed orally, forcing patients to use injections instead. Finding peptides that safely improve gut absorption — without destroying beneficial gut bacteria — could make oral delivery feasible for a much wider range of therapeutics, improving patient compliance and quality of life.

The growing interest in oral peptide and biologic delivery has made cell-penetrating peptides a hot area of research. This study adds an important dimension by evaluating microbiome safety alongside absorption efficiency — a factor that is increasingly recognized as critical for any oral drug delivery strategy.

All experiments were conducted in vitro using cell monolayers and isolated bacterial strains, which may not fully reflect the complex environment of the human gut. The study did not test actual drug absorption with these CPPs, only permeability markers. In vivo studies are needed to confirm safety and efficacy in living organisms.